Delivery Order SPE2DB20D1110-SPE2DB25FK45R
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $32,431.82 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhaler medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents...
- The Defense Logistics Agency awarded a delivery order valued at $144,377.33 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhaler medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, awarded on September 25, 2025, with completion targeted for September 26, 2025, represents a direct procurement under a non-set-aside competitive process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered...
- The Defense Logistics Agency awarded a $50,306.61 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This non-competitive delivery order, which is scheduled for completion by August 29, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $16,076.36 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination inhaler medication for chronic obstructive pulmonary disease treatment). This competitively awarded, non-set-aside contract carries a ceiling value of $13,468.45 and is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The work will be performed at AmerisourceBergen's Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,199.48 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used for chronic obstructive pulmonary disease treatment. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 19, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $8,719.71 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation medication used to treat chronic obstructive pulmonary disease. Issued on August 4, 2025, with completion targeted for August 5, 2025, this firm fixed-price delivery order represents a non-set-aside competitive award under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a $5,007.60 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The point of performance is...
- The Defense Logistics Agency awarded a $64,939.14 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 11, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,086.50 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhaler medication used to treat chronic obstructive pulmonary disease. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK45RDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,029.37 to AmerisourceBergen Drug Corp for 60 units of Trelegy Ellipta 100-62.5-25, a combination inhaler medication used in the treatment of chronic obstructive pulmonary disease. Issued on September 25, 2025, with an ultimate completion date of September 26, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism. The parent contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. AmerisourceBergen's extensive federal contracting history demonstrates its established capability to meet DLA's pharmaceutical procurement requirements across multiple therapeutic domains through competitive award processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 9/25/25 |